Welcome to DailyUpdates Pain channel - the R&D community's bulletin of breaking research, clinical trials and drug development news. This page will update each day. You have access for 1 more day(s). To receive DailyUpdates by e-mail register here


PubMed DailyUpdates: Breaking Scientific Publications for the Drug Discovery Community

DailyUpdates by e-mail - the publication tracker for the drug discovery community

Pain channel



If this icon appears after any of our listed articles, the author is able to provide reprints. Articles denoted by an Licensing Op. icon describe data relevant to licensing opportunities. The report icon, , links through to full analyses relating to pharmaceutical/market developments relating to this work

Today's journal articles

No journal articles today

Do you need further information on any of the agents being evaluated in the trial(s) below?  Let us know...

New Clinical Trials

No clinical trials today

Previous Journal Entries

Gabapentin (Neurontin(R)) improves pain scores of patients with critical limb ischaemia: An observational study.

Role of Low-Affinity Nerve Growth Factor Receptor Inhibitory Antibody in Reducing Pain Behavior and Calcitonin Gene-Related Peptide Expression in a Rat Model of Wrist Joint Inflammatory Pain.

Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin.

The involvement of the transient receptor potential A1 (TRPA1) in the maintenance of mechanical and cold hyperalgesia in persistent inflammation.

Development of a self-reporting tool to obtain a Combined Index of Severity of Fibromyalgia (ICAF*).

The Antinociceptive Effect of Sigma-1 Receptor Antagonist, BD1047, in a Capsaicin Induced Headache Model in Rats.

Comparative Pharmacokinetics of a Once-Daily Tramadol Extended-Release Tablet and an Immediate-Release Reference Product Following Single-Dose and Multiple-Dose Administration.

Predictive screening model for potential vector - mediated transport of cationic substrates at the blood - brain barrier choline transporter.

Discovery and optimization of RO - 85, a novel drug - like, potent, and selective P2X(3) receptor antagonist.

Interaction of physostigmine and alfentanil in a human pain model.

Peripheral antinociceptive effect of 2-arachidonoyl-glycerol and its interaction with endomorphin-1 in arthritic rat ankle joints.

A Prospective, Randomized Trial of Intravenous Prochlorperazine Versus Subcutaneous Sumatriptan in Acute Migraine Therapy in the Emergency Department.

Design, synthesis and SAR analysis of novel selective sigma(1) ligands (Part 2).

Oxime Carbamate - Discovery of a series of novel FAAH inhibitors.

Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine.

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Efficacy of Periarticular Injection of Bupivacaine, Fentanyl, and Methylprednisolone in Total Knee Arthroplasty A Prospective, Randomized Trial.

Synthesis, Nicotinic Acetylcholine Receptor Binding, and Antinociceptive Properties of 3'-(Substituted Phenyl)epibatidine Analogues. Nicotinic Partial Agonists ( perpendicular).

Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain.

Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.

Today's News Items

Cara Therapeutics Reports Positive Phase II Data for Novel Peripheral Analgesic In Acute Post-Operative Pain

Training Courses & Meetings

No events listed

Previous News Items

Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study

POSITIVE RESULTS FROM PHASE 1B STUDY OF PHOSPHAGENICS’ TRANSDERMAL OXYCODONE PATCH

FDA Accepts Javelin Pharmaceuticals\' Dyloject™ New Drug Application for Formal Review